Search
for
Sort by
Research 241–270 of 533
- Alopecia Areata: Current Treatments and New Directions
- Immune therapies for alopecia areata: evidence and new perspectives
- New Modalities in the Treatment of Refractory Alopecia Areata
- Vitiligo—Current Treatment Options and Future Perspectives
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- Pyroptosis in Alopecia Areata: Synthesizing Emerging Hypotheses and Charting a Path to New Therapies
- Real-world evidence in alopecia areata treatment: A narrative review
- Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata
- mTOR signaling in hair follicle and hair diseases: recent progress
- Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023)
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- Alopecia Areata in Skin of Color Patients: New Considerations Sparked by the Approval of Baricitinib
- Real-life effectiveness and safety of baricitinib in 17 Japanese patients with alopecia areata: a 60-week single center study
- Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies
- Skin Pigmentation Types, Causes and Treatment—A Review
- Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention
- Resident Memory T Cells in Autoimmune Skin Diseases
- A Comprehensive Review on Skin Pigmentation-Types, Causes, and Treatment
- Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Two cases of alopecia areata treated with ruxolitinib: a discussion of ideal dosing and laboratory monitoring
- Consensus on the treatment of alopecia areata – Brazilian Society of Dermatology
- Palmoplantar pustulosis–like eruption following tofacitinib therapy for juvenile idiopathic arthritis
- Application of Baricitinib in Dermatology
- Alopecia areata – Current understanding and management
- Good efficacy achieved by baricitinib in the treatment of anti-MDA5 antibody-positive dermatomyositis with alopecia areata
- Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1
- Alopecia areata – Aktuelles Verständnis und Management